Literature DB >> 4055050

Cefotaxime: efficacy and tolerance in lower respiratory tract infections caused by gram-positive cocci.

H Lode, P D Glatzel.   

Abstract

Cefotaxime is an effective antibiotic in lower respiratory tract infection caused by streptococci and staphylococci. There is a limited tendency to superinfections with Pseudomonas aeruginosa (1.5%) and there is a low incidence of side-effects. It is questionable whether there is really an urgent need for cefotaxime in gram-positive lower respiratory tract infections.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4055050     DOI: 10.1007/BF01644213

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  15 in total

1.  Cefotaxime in the treatment of pneumococcal pneumonia.

Authors:  S G Jenkinson; M S Briggs; R D Bryn
Journal:  J Antimicrob Chemother       Date:  1980-09       Impact factor: 5.790

2.  Cefotaxime in the treatment of severe paediatric infections.

Authors:  C J Papadatos; D A Kafetzis; J Kanarios
Journal:  J Antimicrob Chemother       Date:  1980-09       Impact factor: 5.790

3.  Cefotaxime in lower respiratory tract infections compared to cefazolin.

Authors:  F Miki; K Shiota
Journal:  J Antimicrob Chemother       Date:  1980-09       Impact factor: 5.790

4.  Cefotaxime in bronchopulmonary infections--a clinical and pharmacological study.

Authors:  H Lode; B Kemmerich; G Gruhlke; G Dzwillo; P Koeppe; I Wagner
Journal:  J Antimicrob Chemother       Date:  1980-09       Impact factor: 5.790

5.  Cefotaxime in the treatment of lower respiratory tract infections.

Authors:  P Hänninen; A Toivanen; O Vainio; P Toivanen
Journal:  J Antimicrob Chemother       Date:  1980-09       Impact factor: 5.790

6.  The use of cefotaxime in pneumology.

Authors:  C Grassi; M L Colombo; V Peona
Journal:  Acta Med Port       Date:  1983-02

7.  Cefotaxime in the treatment of lower respiratory tract infections.

Authors:  H M Beumer; J Veldkamp; L Deleers
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1983-12

8.  Clinical trials of cefotaxime for the treatment of bacterial infections of the lower respiratory tract.

Authors:  R L Perkins
Journal:  Rev Infect Dis       Date:  1982 Sep-Oct

9.  Clinical efficacy of cefotaxime in serious infections.

Authors:  P H Karakusis; J M Feczko; L J Goodman; D M Hanlon; A A Harris; S Levin; G M Trenholme
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

10.  Use of cefotaxime, a beta-lactamase stable cephalosporin, in the therapy of serious infections, including those due to multiresistant organisms.

Authors:  E L Francke; H C Neu
Journal:  Am J Med       Date:  1981-09       Impact factor: 4.965

View more
  1 in total

Review 1.  Cefotaxime. An update of its pharmacology and therapeutic use.

Authors:  P A Todd; R N Brogden
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.